The Current Ratio as of November 2024 (TTM) for Oramed Pharmaceuticals Inc. (ORMP) is 2.25

According to Oramed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.25. This represents a change of -95.56% compared to the average of 50.57 of the last 4 quarters.

Oramed Pharmaceuticals Inc. (ORMP) Historical Current Ratio (quarterly & annually)

How has ORMP Current Ratio performed in the past?

The mean historical Current Ratio of Oramed Pharmaceuticals Inc. over the last ten years is 12.76. The current 2.25 Current Ratio has changed 1.66% with respect to the historical average. Over the past ten years (40 quarters), ORMP's Current Ratio was at its highest in in the June 2023 quarter at 141.49. The Current Ratio was at its lowest in in the September 2023 quarter at 2.25.

Oramed Pharmaceuticals Inc. (ORMP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Oramed Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oramed Pharmaceuticals Inc. (ORMP) Average Current Ratio

How has ORMP Current Ratio performed in the past?

The current Current Ratio of Oramed Pharmaceuticals Inc. (ORMP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Oramed Pharmaceuticals Inc. (ORMP) Current Ratio vs. Peers

How is ORMP’s Current Ratio compared to its peers?

Oramed Pharmaceuticals Inc.’s Current Ratio is greater than Protalix BioTherapeutics, Inc. (1.98), greater than Corvus Pharmaceuticals, Inc. (0.92), less than Aldeyra Therapeutics, Inc. (6.80), greater than Gamida Cell Ltd. (0.35), greater than Checkpoint Therapeutics, Inc. (0.29), greater than BioLineRx Ltd. (1.61), less than Ardelyx, Inc. (4.03), less than Lexicon Pharmaceuticals, Inc. (7.45), greater than Seres Therapeutics, Inc. (1.12), less than ImmunityBio, Inc. (2.68), less than X4 Pharmaceuticals, Inc. (4.89), less than Mereo BioPharma Group plc (6.10), less than Inozyme Pharma, Inc. (7.68), less than Terns Pharmaceuticals, Inc. (32.99), less than Leap Therapeutics, Inc. (3.97), less than Zura Bio Limited (10.36), greater than Altamira Therapeutics Ltd. (1.38), less than Immix Biopharma, Inc. (3.47), less than Enveric Biosciences, Inc. (5.17), less than Palisade Bio, Inc. (3.31), greater than Hepion Pharmaceuticals, Inc. (1.30), less than AVROBIO, Inc. (26.17), less than CohBar, Inc. (15.69), greater than Ocean Biomedical, Inc. (0.03), less than Elevation Oncology, Inc. (17.77),

Build a custom stock screener for Oramed Pharmaceuticals Inc. (ORMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oramed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oramed Pharmaceuticals Inc. (ORMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oramed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.